Multiple Manufacturers

EPOPROSTENOL SODIUM

Manufacturer:

Multiple Manufacturers

Epoprostenol Sodium HCPCS:

J1325

HCPCS Code Descriptor:

Injection, epoprostenol, 0.5 mg

Category:

J Code

Epoprostenol Sodium NDCs:

66215-0402-01, 00173-0519-00, 62756-0060-40, 66215-0403-01, 62756-0059-40, 00173-0517-00

Primary Type:

Cardiology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00173-0519-00, 00173-0517-00

About Epoprostenol Sodium:

EPOPROSTENOL SODIUM is a Cardiology drug manufactured by Teva and administered via the Intravenous route of administration. The J Code: J1325 is aligned to the drug EPOPROSTENOL SODIUM.

ACCESS PRICING AND MORE BY REGISTERING

J1325 Added Date:

January 1, 1998

J1325 Effective Date:

January 1, 1998

J1325 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Epoprostenol Sodium billing and coding information.
Our team did not identify a source for Epoprostenol Sodium patient assistance information. Please reach out to our team if you feel that this is a mistake.
EPOPROSTENOL SODIUM prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for EPOPROSTENOL SODIUM. Please check back in a few weeks.